Evidence map›Paper›PMID 25294952›Full record

ArticleMediators of inflammation2014

Ecotin-like ISP of L. major promastigotes fine-tunes macrophage phagocytosis by limiting the pericellular release of bradykinin from surface-bound kininogens: a survival strategy based on the silencing of proinflammatory G-protein coupled kinin B2 and B1 receptors.

Erik Svensjö, Larissa Nogueira de Almeida, Lucas Vellasco, Luiz Juliano, Julio Scharfstein

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Kinins and Their Receptors in Infectious Diseases.Pharmaceuticals (Basel, Switzerland) · 2020
    Review
  3. Article
  4. Inhibitor of serine peptidase 2 enhances Leishmania major survival in the skin through control of monocytes and monocyte-derived cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  5. Bradykinin Sequestration byFrontiers in microbiology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Erik SvensjöInstituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, 21990-400 Rio de Janeiro, RJ, Brazil.
Larissa Nogueira de AlmeidaInstituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, 21990-400 Rio de Janeiro, RJ, Brazil.ORCID 0000-0003-2974-433X
Lucas VellascoInstituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, 21990-400 Rio de Janeiro, RJ, Brazil.
Luiz JulianoEscola Paulista de Medicina, Universidade Federal de São Paulo, 04044-020 São Paulo, SP, Brazil.ORCID 0000-0002-5589-2822
Julio ScharfsteinInstituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, 21990-400 Rio de Janeiro, RJ, Brazil.
Universidade Federal do Rio de Janeiro · BRUniversidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inhibitors of serine peptidases (ISPs) expressed by Leishmania major enhance intracellular parasitism in macrophages by targeting neutrophil elastase (NE), a serine protease that couples phagocytosis to the prooxidative TLR4/PKR pathway. Here we investigated the functional interplay between ISP-expressing L. major and the kallikrein-kinin system (KKS). Enzymatic assays showed that NE inhibitor or recombinant ISP-2 inhibited KKS activation in human plasma activated by dextran sulfate. Intravital microscopy in the hamster cheek pouch showed that topically applied L. major promastigotes (WT and Δisp2/3 mutants) potently induced plasma leakage through the activation of bradykinin B2 receptors (B2R). Next, using mAbs against kininogen domains, we showed that these BK-precursor proteins are sequestered by L. major promastigotes, being expressed at higher % in the Δisp2/3 mutant population. Strikingly, analysis of the role of kinin pathway in the phagocytic uptake of L. major revealed that antagonists of B2R or B1R reversed the upregulated uptake of Δisp2/3 mutants without inhibiting macrophage internalization of WT L. major. Collectively, our results suggest that L. major ISP-2 fine-tunes macrophage phagocytosis by inhibiting the pericellular release of proinflammatory kinins from surface bound kininogens. Ongoing studies should clarify whether L. major ISP-2 subverts TLR4/PKR-dependent prooxidative responses of macrophages by preventing activation of G-protein coupled B2R/B1R.

Indexed as

AnimalsBradykininBradykinin B2 Receptor AntagonistsCricetinaeHumansKininogensKininsLeishmania majorLeukocyte ElastaseMacrophagesMalePhagocytosisReceptor, Bradykinin B1Receptor, Bradykinin B2Serine Proteinase InhibitorsBradykininBradykinin B2 Receptor AntagonistsicatibantKininogensKininsLeukocyte ElastaseReceptor, Bradykinin B1Receptor, Bradykinin B2Serine Proteinase Inhibitors

Identifiers

PMID25294952
PMCPMC4177093
OpenAlexW2098054105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.